Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Developments in Ophthalmology|April 16, 2014
Regulatory issues in cell-based therapy for clinical purposesRicardo P Casaroli-Marano, Jaime Tabera, Anna Vilarrodona, et al.International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|May 16, 2019
EuroGTP II: a tool to assess risk, safety and efficacy of substances of human originEsteve Trias, Richard Lomas, Jaime Tabera, et al.Therapeutics and Clinical Risk Management|July 10, 2023
Quality by Design: Development of Safe and Efficacious Full-Thickness Acellular Dermal Matrix Based on EuroGTPII MethodologiesPatricia López-Chicón, Maria Luisa Pérez, Cristina Castells-Sala, et al.Cell and Tissue Banking|February 6, 2020
Banking of corneal stromal lenticules: a risk-analysis assessment with the EuroGTP II interactive toolEsteve Trias, Paola Gallon, Stefano Ferrari, et al.BMJ Open Ophthalmology|June 7, 2023
4 New strategies in the barcelona eye bank to minimize the impact of the COVID-19 pandemicEva M Martinez-Conesa, Nausica Otero, Patricia Lopez, et al.Therapeutics and Clinical Risk Management|March 4, 2025
Advancing Heart Valve Replacement: Risk Mitigation of Decellularized Pulmonary Valve Preparation for Its Implementation in Public Tissue BanksJose Ignacio Rodríguez Martínez, Cristina Castells-Sala, Ana Rita Baptista Piteira, et al.European Journal of Cancer (Oxford, England : 1990)|July 19, 2016
Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patientsMiguel Caballero-Baños, Daniel Benitez-Ribas, Jaime Tabera, et al.Frontiers in Immunology|June 13, 2020
Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical TrialMaria Castella, Miguel Caballero-Baños, Valentín Ortiz-Maldonado, et al.Molecular Therapy. Methods & Clinical Development|January 10, 2019
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic InstitutionsMaria Castella, Anna Boronat, Raquel Martín-Ibáñez, et al.Pageof 1